Catalent Inc.

In News

Catalent and Mantra™ Announce Commercial Supply Agreement for Single-Serve Oral Gel Portfolio - Business Wire

Business Wire - Oct 12, 2026

Catalent Launches Accelerated Gene-to-Drug Substance Program for Complex Molecules in the U.S. - BioSpace

BioSpace - Oct 05, 2026

ALK expands strategic tablet supply partnership with Catalent - Yahoo Finance

Yahoo Finance - Sep 30, 2026

Catalent, Inc. Launches Accelerated Gene-To-Drug Substance Program For Complex Biologics In The U.S - www.marketscreener.com

www.marketscreener.com - Oct 05, 2026

Taysha Gene Therapies and Catalent Expand Strategic - GlobeNewswire

GlobeNewswire - Aug 03, 2026

Catalent $78M Securities Class Class Action Settlement - Claim Depot

Claim Depot - Jan 20, 2026

Scholar Rock’s Apitegromab Filing Exposes the CMO Due Diligence Gap That Keeps Burning Sponsors - The Clinical Trial Vanguard

The Clinical Trial Vanguard - Aug 11, 2026

Catalent and Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of Lead Optogenetic Gene therapy, MCO-010 - PR Newswire

PR Newswire - Jul 07, 2026

Catalent and Elpida Therapeutics Join Forces for Gene Therapy Scale-Up - CHEManager

CHEManager - May 20, 2026

Catalent moves to wind down operations at EU cell therapy manufacturing hub - Fierce Pharma

Fierce Pharma - Jan 26, 2026

Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases - BioInformant

BioInformant - Mar 31, 2026

Catalent Completes $4.1 Billion Debt Refinancing, Cutting Annual Interest by $100 Million - citybiz

citybiz - Aug 25, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment